Status | Study |
Completed |
Study Name: The Primordial Dwarfisms: Diagnosis, Identification of the Molecular Basis of Seckel Syndrome and Microcephalic Osteodysplastic Primordial Dwarfism Type II Condition: Microcephalic Osteodysplastic Primordial Dwarfism Type II Secke Date: 2017-03-23 |
Completed |
Study Name: Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children Condition: Short Stature Date: 2016-08-10 Interventions: Drug: Genotropin Children were randomized to either decreased dose by 50% or unchanged dose after 2-3 ye |
Active, not recruiting |
Study Name: IGF-1 Treatment for Individuals With Short Stature Due to PAPP-A2 Deficiency Condition: Short Stature Date: 2015-11-10 Interventions: Drug: Increlex Treat PAPP-A2 deficient patients with Increlex |
Recruiting |
Study Name: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Condition: Dwarfism, Pituitary Date: 2014-11-27 Interventions: Biological: PEG-somatropin |
Completed |
Study Name: The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature Condition: Short Stature Date: 2013-10-23 Interventions: Drug: Growth Hormone Will obtain daily injections and will evaluate the IGF-1 and IGFBP3 every 3 months |
Completed |
Study Name: Efficacy and Safety of DA-3002 in Children With Idiopathic Short Stature Condition: Idiopathic Short Stature Date: 2013-02-06 Interventions: Drug: DA-3002 Other Name: Recombinant Human Growth Hormone |
Completed |
Study Name: Efficacy and Safety of Recombinant Human Growth Hormone on Height Velocity in Subjects With Idiopathic Short Stature Condition: Growth Disorder Idiopathic Short Stature Date: 2013-01-24 Interventions: Drug: somatropin A weekly dosage of 0.469 mg of somatropin per kg of body weight per week will be inject |
Completed |
Study Name: A Phase 3 Study to Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS) Condition: Idiopathic Short Stature Date: 2012-11-30 Interventions: Drug: Saizen® Subjects in |
Completed |
Study Name: Pharmacodynamics of CNP During Growth Hormone Treatment Condition: Pituitary Dwarfism Idiopathic Short Statu Date: 2011-07-20 |
Recruiting |
Study Name: Short Stature Related Distress Condition: Idiopathic Short Stature Self Image Date: 2010-11-16 Interventions: Drug: GH treatment (Genotropin) |